Blackstone Group »

Sab Biotherapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 860k 3.83
2025-12-31 $8.0M 2.1M 3.74

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Corebridge Finl (CRBG)
FirstEnergy (FE)
Legence Corp Cl A (LGN)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Williams Companies (WMB)
MPLX Com Unit Rep Ltd (MPLX)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Enbridge (ENB)
Kinder Morgan (KMI)
Energy Transfer Com Ut Ltd Ptn (ET)
Kinetik Holdings Com New Cl A (KNTK)
Cheniere Energy Com New (LNG)
PNM Resources (TXNM)

View all positions for Blackstone Group

Top funds holding Sab Biotherapeutics

Vivo Capital
Perceptive Advisors
Commodore Capital
RA Capital Management
Balyasny Asset Management
Millennium Management
Woodline Partners
Vanguard Capital Management
Sessa Capital IM
Vanguard Group
Boothbay Fund Management
Ameriprise Financial
Ensign Peak Advisors
Soleus Capital Management
Propel Bio Management

View all funds holding Sab Biotherapeutics